{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:19:15Z","timestamp":1790630355462,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":3904,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.bbmt.2004.04.002","type":"journal-article","created":{"date-parts":[[2004,7,27]],"date-time":"2004-07-27T17:39:35Z","timestamp":1090949975000},"page":"552-560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation"],"prefix":"10.1016","volume":"10","author":[{"given":"Paul J.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Gooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Anasetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick R.","family":"Appelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Deeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effie W.","family":"Petersdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Storb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Ghetie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen S.","family":"Vitetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2004.04.002_BIB1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJM199103073241005","article-title":"Graft-versus-host disease","volume":"324","author":"Ferrara","year":"1991","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB2","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1084\/jem.158.6.1895","article-title":"Transient expression of interleukin-2 receptors. Consequences for T cell growth","volume":"158","author":"Cantrell","year":"1983","journal-title":"J Exp Med."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-065X.1980.tb00327.x","article-title":"T cell growth factor","volume":"51","author":"Smith","year":"1980","journal-title":"Immunol Rev."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60386-7","article-title":"Biology of the interleukin-2 receptor","volume":"70","author":"Nelson","year":"1998","journal-title":"Adv Immunol."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00007890-199007000-00010","article-title":"A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease","volume":"50","author":"Anasetti","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2004.04.002_BIB6","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1182\/blood.V84.4.1320.1320","article-title":"Treatment of acute graft-versus-host disease with humanized anti-Tac","volume":"84","author":"Anasetti","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2004.04.002_BIB7","first-page":"375","article-title":"Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3","volume":"7","author":"Anasetti","year":"1991","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB8","first-page":"621a","article-title":"A phase II\/III randomized, double-blind, placebo-controlled multicenter trial of humanized anti-Tac for prevention of acute graft-versus-host disease (GVHD) in recipients of marrow transplantation from unrelated donors","volume":"86","author":"Anasetti","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2004.04.002_BIB9","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0140-6736(95)90978-8","article-title":"Impairment of leukemia-free survival by addition of interleukin-2 receptor antibody to standard graft-versus-host prophylaxis","volume":"345","author":"Blaise","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2004.04.002_BIB10","first-page":"293","article-title":"Use of an anti-interleukin-2 receptor monoclonal antibody for GVHD prophylaxis in unrelated donor BMT","volume":"11","author":"Belanger","year":"1993","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ijc.2910490324","article-title":"Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent antitumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice","volume":"49","author":"Engert","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bbmt.2004.04.002_BIB12","first-page":"6396","article-title":"Improved anti-tumor effects of immunotoxins prepared with deglycosylated ricin A-chain and hindered disulfide linkages","volume":"48","author":"Thorpe","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB13","first-page":"947","article-title":"Effect of chemical deglycosylation of ricin A-chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A-chain and anti-Thy1.1 antibody","volume":"47","author":"Blakey","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB14","first-page":"2618","article-title":"Pharmacokinetics of tumor-reactive immunotoxins in tumor-bearing mice","volume":"48","author":"Fulton","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB15","doi-asserted-by":"crossref","first-page":"15358","DOI":"10.1073\/pnas.93.26.15358","article-title":"Definition of HLA-DQ as a transplantation antigen","volume":"93","author":"Petersdorf","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbmt.2004.04.002_BIB16","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1056\/NEJMoa011826","article-title":"Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation","volume":"345","author":"Petersdorf","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJM198603203141201","article-title":"Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia","volume":"314","author":"Storb","year":"1986","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB18","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation\u2014a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB19","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V88.10.4063.bloodjournal88104063","article-title":"Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation","volume":"88","author":"Boeckh","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2004.04.002_BIB20","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood.V93.5.1781","article-title":"Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients","volume":"93","author":"Boeckh","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2004.04.002_BIB21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/blood.V89.2.403","article-title":"A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin\u2019s lymphoma","volume":"89","author":"Engert","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2004.04.002_BIB22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/03602538608998295","article-title":"A basic interactive complex program for statistical and pharmacokinetic analysis of data","volume":"17","author":"Shumaker","year":"1986","journal-title":"Drug Metab Rev."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0197-2456(94)90003-5","article-title":"Simulation as a design tool for phase I\/II clinical trials","volume":"15","author":"Gooley","year":"1994","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.bbmt.2004.04.002_BIB24","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1182\/blood.V94.7.2192.419a38_2192_2199","article-title":"A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients","volume":"94","author":"Martin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2004.04.002_BIB25","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1084\/jem.163.4.998","article-title":"Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences","volume":"163","author":"Sprent","year":"1986","journal-title":"J Exp Med."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB26","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood.V88.3.962.962","article-title":"Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation","volume":"88","author":"Martin","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2004.04.002_BIB27","first-page":"4052","article-title":"Phase I immunotoxin trial in patients with B-cell lymphoma","volume":"51","author":"Vitetta","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB28","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood.V82.9.2624.2624","article-title":"A phase I study of an anti-CD22-deglycosylated ricin A-chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy","volume":"82","author":"Amlot","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2004.04.002_BIB29","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1182\/blood.V85.12.3457.bloodjournal85123457","article-title":"Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma","volume":"85","author":"Sausville","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2004.04.002_BIB30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.leu.2401626","article-title":"Treatment of refractory Hodgkin\u2019s lymphoma patients with an anti-CD25 ricin A-chain immunotoxin","volume":"14","author":"Schnell","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2004.04.002_BIB31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","article-title":"Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells","volume":"182","author":"Sakaguchi","year":"2001","journal-title":"Immunol Rev."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1034\/j.1600-065X.2001.1820104.x","article-title":"Control of T-cell activation by CD4+ CD25+ suppressor T cells","volume":"182","author":"Shevach","year":"2001","journal-title":"Immunol Rev."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB33","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ni0901-816","article-title":"Regulatory T cells in the control of immune pathology","volume":"2","author":"Maloy","year":"2001","journal-title":"Nat Immunol."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB34","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.188.2.287","article-title":"CD4+ CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin-2 production","volume":"188","author":"Thornton","year":"1998","journal-title":"J Exp Med."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB36","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/intimm\/10.12.1969","article-title":"Immunologic self-tolerance maintained by CD25+ CD4+ naturally anergic and suppressive T cells","volume":"10","author":"Takahashi","year":"1998","journal-title":"Int Immunol."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB37","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3435::AID-IMMU3435>3.0.CO;2-P","article-title":"CD38+ CD45RBlow CD4+ T cells","volume":"28","author":"Read","year":"1998","journal-title":"Eur J Immunol."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB38","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1084\/jem.183.6.2669","article-title":"A critical role for transforming growth factor \u03b2 but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RBlow CD4+ T cells","volume":"183","author":"Powrie","year":"1996","journal-title":"J Exp Med."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1084\/jem.192.2.295","article-title":"Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+ CD4+ regulatory cells that control intestinal inflammation","volume":"192","author":"Read","year":"2000","journal-title":"J Exp Med."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB40","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.190.7.995","article-title":"An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation","volume":"190","author":"Asseman","year":"1999","journal-title":"J Exp Med."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB41","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.4049\/jimmunol.166.5.3008","article-title":"CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10","volume":"166","author":"Annacker","year":"2001","journal-title":"J Immunol."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1084\/jem.20020590","article-title":"CD4+CD25+ regulatory cells can mediate suppressor function in the absence of transforming growth factor \u03b21 production and responsiveness","volume":"196","author":"Piccirillo","year":"2002","journal-title":"J Exp Med."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB43","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1084\/jem.193.11.1311","article-title":"CD4+ CD25+ immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade","volume":"193","author":"Taylor","year":"2001","journal-title":"J Exp Med."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB44","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.V99.10.3493","article-title":"The infusion of ex-vivo activated and expanded CD4+ CD25+ immune regulatory cells inhibits graft-versus-host disease lethality","volume":"99","author":"Taylor","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2004.04.002_BIB45","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.193.11.1285","article-title":"Identification and functional characterization of human CD4+ CD25+ T cells with regulatory properties isolated from peripheral blood","volume":"193","author":"Jonuleit","year":"2001","journal-title":"J Exp Med."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB46","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1084\/jem.193.11.1295","article-title":"Human CD25+ CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function","volume":"193","author":"Levings","year":"2001","journal-title":"J Exp Med."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB47","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.193.11.1303","article-title":"Ex vivo isolation and characterization of CD4+ CD25+ T cells with regulatory properties from human blood","volume":"193","author":"Dieckmann","year":"2001","journal-title":"J Exp Med."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1084\/jem.20020642","article-title":"Human CD4+ CD25+ regulatory, contact-dependent T cells induce interleukin-1-producing, contact-independent type 1-like regulatory cells","volume":"196","author":"Dieckmann","year":"2002","journal-title":"J Exp Med."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB49","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.20020394","article-title":"Infectious tolerance","volume":"196","author":"Jonuleit","year":"2002","journal-title":"J Exp Med."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB50","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0140-6736(02)09413-8","article-title":"Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation","volume":"360","author":"Andre-Schmutz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2004.04.002_BIB51","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0301-472X(03)00228-5","article-title":"Humanized anti-CD25 monoclonal antibody for prophylaxis of graft-versus-host disease (GVHD) in haploidentical bone marrow transplantation without ex vivo T-cell depletion","volume":"31","author":"Chen","year":"2003","journal-title":"Exp Hematol."},{"key":"10.1016\/j.bbmt.2004.04.002_BIB52","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.TP.0000109643.32659.C4","article-title":"Interleukin 2 receptor antagonists for renal transplant recipients","volume":"77","author":"Webster","year":"2004","journal-title":"Transplantation"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879104002009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879104002009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:21:17Z","timestamp":1761056477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879104002009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S1083879104002009"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2004.04.002","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2004.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}